Literature DB >> 2182978

A comparison of 'active' and 'physiological' management of the third stage of labour.

C M Begley.   

Abstract

A randomised, controlled trial of 1429 women was carried out to compare 'active' management of the third stage of labour, using i.v. Ergometrine 0.5 mg, with a method of 'physiological' management, in women at 'low risk' to haemorrhage. In the "active" management group a higher incidence of the following complications was found:- manual removal of placenta (p less than 0.0005), problems such as nausea (p less than 0.0005), vomiting (p less than 0.0005), and severe after-birth pains (p less than 0.02), hypertension (p less than 0.0001) and secondary postpartum haemorrhage (p less than 0.02). The incidence of postpartum haemorrhage (blood loss greater than 500 ml) and postnatal haemoglobins less than 10 gm/100 were higher in the 'physiological' group (p less than 0.0005, p less than 0.002). No difference was found in the need for blood transfusion in either group. The routine use of i.v. Ergometrine 0.5 mg during the third stage of labour in women at 'low risk' to haemorrhage does not appear to be necessary and has many adverse effects. Further studies comparing different methods of 'physiological' management are recommended in order to reduce to a minimum the incidence of postpartum haemorrhage and anaemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182978     DOI: 10.1016/s0266-6138(05)80091-9

Source DB:  PubMed          Journal:  Midwifery        ISSN: 0266-6138            Impact factor:   2.372


  18 in total

Review 1.  Active versus expectant management for women in the third stage of labour.

Authors:  Cecily M Begley; Gillian M L Gyte; Declan Devane; William McGuire; Andrew Weeks
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 2.  The retained placenta.

Authors:  A D Weeks
Journal:  Afr Health Sci       Date:  2001-08       Impact factor: 0.927

Review 3.  What measured blood loss tells us about postpartum bleeding: a systematic review.

Authors:  N L Sloan; J Durocher; T Aldrich; J Blum; B Winikoff
Journal:  BJOG       Date:  2010-04-20       Impact factor: 6.531

Review 4.  Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology.

Authors:  A N de Groot; P W van Dongen; T B Vree; Y A Hekster; J van Roosmalen
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

5.  Antenatal screening: its use in assessing obstetric risk factors in Zimbabwe.

Authors:  V D Tsu
Journal:  J Epidemiol Community Health       Date:  1994-06       Impact factor: 3.710

6.  Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour.

Authors:  S J McDonald; W J Prendiville; E Blair
Journal:  BMJ       Date:  1993-11-06

7.  Active versus expectant management for women in the third stage of labour.

Authors:  Cecily M Begley; Gillian Ml Gyte; Declan Devane; William McGuire; Andrew Weeks; Linda M Biesty
Journal:  Cochrane Database Syst Rev       Date:  2019-02-13

8.  Umbilical vein injection for management of retained placenta.

Authors:  Nimisha Kumar; Shayesteh Jahanfar; David M Haas; Andrew D Weeks
Journal:  Cochrane Database Syst Rev       Date:  2021-03-11

Review 9.  Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes.

Authors:  Susan J McDonald; Philippa Middleton; Therese Dowswell; Peter S Morris
Journal:  Cochrane Database Syst Rev       Date:  2013-07-11

10.  Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR).

Authors:  Catherine Deneux-Tharaux; Loic Sentilhes; Françoise Maillard; Emmanuel Closset; Delphine Vardon; Jacques Lepercq; François Goffinet
Journal:  BMJ       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.